Tutorials
AVITA Medical Inc logo

AVITA Medical Inc

A$ 2.31 (+13.24%) Aug 8
P/E:
At Loss
P/B:
1.85
Market Cap:
A$ 254.45M ($ 177.48M)
Enterprise V:
A$ 135.26M ($ 94.35M)
Volume:
534.77K
Avg Vol (2M):
318.94K
Also Trade In:
Volume:
534.77K
Market Cap A$:
254.45M
Market Cap $:
177.48M
PE Ratio:
At Loss
Avg Vol (2-Month):
318.94K
Enterprise Value A$:
135.26M
Enterprise Value $:
94.35M
PB Ratio:
1.85
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

AVITA Medical Inc
NAICS : 339112 SIC : 5047
28159 Avenue Stanford, Suite 220, Valencia, Los Angeles, CA, USA, 91355
Description
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centres. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the U.S.
Name Current Vs Industry Vs History
Cash-To-Debt 114.84
Equity-to-Asset 0.92
Debt-to-Equity 0.01
Debt-to-EBITDA -0.03
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 9.65
Distress
Grey
Safe
Beneish M-Score 2.82
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 91.19
9-Day RSI 83.86
14-Day RSI 77.09
6-1 Month Momentum % -34.16
12-1 Month Momentum % -66.11

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 13.96
Quick Ratio 13.68
Cash Ratio 12.83
Days Inventory 113.52
Days Sales Outstanding 35.28
Days Payable 184.44

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 27

Financials (Next Earnings Date:2022-08-11)

ASX:AVH's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 43
EPS (TTM) (A$) -0.314
Beta 0.69
Volatility % 36.73
14-Day RSI 77.09
14-Day ATR (A$) 0.121705
20-Day SMA (A$) 1.74125
12-1 Month Momentum % -66.11
52-Week Range (A$) 1.28 - 5.7
Shares Outstanding (Mil) 124.78

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

AVITA Medical Inc Filings

Document Form Filing Date
No Filing Data